Status:
COMPLETED
Rapid Detection of COVID-19 by Portable and Connected Biosensor
Lead Sponsor:
University Hospital, Lille
Conditions:
Sars-CoV2
Eligibility:
All Genders
Brief Summary
The objective of study is to estimate the sensitivity and specificity of the COR-DIAL based on nasopharyngeal samples taken at the patient's admission in relation to the final diagnosis of COVID-19 ma...
Eligibility Criteria
Inclusion
- Male or female or child without age limit
- Admitted to a Reference Health Establishment in an emergency unit, hospitalisation or intensive care unit for suspicion of SARS-CoV-2 infection, regardless of the clinical presentation and degree of severity.
- Patient to be diagnosed using a PCR test on nasopharyngeal swab.
- Social insured
Exclusion
- Atypical or suspicious cases without a final diagnosis of COVID-19 positive or negative
- Patient refusal to participate
Key Trial Info
Start Date :
August 24 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 2 2023
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04367142
Start Date
August 24 2020
End Date
May 2 2023
Last Update
December 17 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU lille
Lille, France, 59037